tak-573
Showing 1 - 1 of 1
Relapsed and/or Refractory Multiple Myeloma Trial (TAK-573, Pomalidomide, Bortezomib)
Withdrawn
- Relapsed and/or Refractory Multiple Myeloma
- TAK-573
- +4 more
- (no location specified)
Jul 10, 2020